MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Free Cash flow
$11,740K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from issuance of conver...
Accrued compensation
Depreciation
Others
Negative Cash Flow Breakdown
Repayment of convertible debt
Premiums paid for capped call co...
Impairment charges
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
2,238
-17,106
-9,881
-27,129
Depreciation
8,576
8,780
8,763
8,803
Amortization of intangibles
7,634
7,633
7,632
7,634
Stock-based compensation
8,216
9,636
8,042
10,306
Non-cash operating lease expense
1,506
1,720
1,713
1,686
Non-cash finance lease amortization
322
-
-
-
Amortization of debt issue costs
20
-
9
9
Amortization of convertible debt discount
753
-
374
372
Gain on debt extinguishment
11,181
-
-
-
Loss (gain) on disposal of assets, net
-
-
-31
-
Impairment charges
-27,127
-
-
7,086
Impairment charges (note 3 and note 7)
-
-
27,753
-
Other impairment charges
-
-
-
0
Impairment of long-lived assets
-
-
0
-
Other adjustments
-417
402
-326
343
Accounts receivable, net
7,981
8,182
4,207
2,368
Inventories
-2,700
1,271
28
-5,632
Prepaid and other assets
1,457
1,395
-3,205
514
Operating lease liabilities
-1,300
-1,299
-1,233
-795
Finance lease liabilities
70
-
-
-
Deferred income tax liabilities, net
626
769
2,694
-869
Accrued compensation
15,689
-7,004
-4,098
2,773
Accounts payable and other liabilities
-4,803
718
-6,585
-5,823
Net cash provided by (used in) operating activities
19,959
-8,137
1,343
8,884
Purchases of marketable securities
-
-
0
-
Proceeds from maturities of marketable securities
0
0
0
9,000
Purchase of equity securities
-
-
0
500
Purchases of property and equipment
8,219
5,000
7,871
8,314
Proceeds from assets held for sale, net of closing costs
-
-
2,066
-
Business acquisition, net of cash acquired
0
-
0
463
Purchase of convertible note
100
-
500
-
Net cash used in investing activities
-8,319
-5,000
-6,305
-277
Proceeds from issuance of convertible debt, net of discount
305,434
-
-
-
Repayment of convertible debt
262,890
-
0
0
Premiums paid for capped call confirmations
28,747
-
-
-
Proceeds received from capped call terminations
77
-
-
-
Repurchases of common stock
25,000
-
-
-
Repayment of financing leases
1,313
-
0
-
Proceeds from issuance of common stock under employee stock purchase plan
2,090
-338
431
765
Proceeds from issuance of common stock upon exercise of stock options
1,273
-
-
-
Employee taxes paid related to net share settlement of restricted stock
3,168
-
-
-
Net cash used in financing activities
-12,244
-338
431
765
Net change in cash and cash equivalents, including cash classified within current assets held for sale
-604
-13,475
-4,531
9,372
Less net change in cash classified within current assets held for sale
32
-
-
22
Net change in cash and cash equivalents
188,816
-
-
9,394
Cash and cash equivalents, beginning of period
146,143
159,618
164,117
367,012
Cash and cash equivalents, end of period
145,539
146,143
159,618
164,117
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
something is missing
$189,388K
Less net change in
cash classified...
$32K
(159.26%↑ Y/Y)
something is missing
$27,127K
Accrued compensation
$15,689K
(209.41%↑ Y/Y)
Depreciation
$8,576K
(-53.66%↓ Y/Y)
Stock-based compensation
$8,216K
(-64.23%↓ Y/Y)
Amortization of intangibles
$7,634K
(-53.69%↓ Y/Y)
Inventories
-$2,700K
(-137.78%↓ Y/Y)
Net loss
$2,238K
(103.15%↑ Y/Y)
Non-cash operating lease
expense
$1,506K
(-55.08%↓ Y/Y)
Amortization of convertible
debt discount
$753K
(-35.31%↓ Y/Y)
Non-cash finance lease
amortization
$322K
Finance lease
liabilities
$70K
Amortization of debt issue
costs
$20K
(-71.01%↓ Y/Y)
Net change in cash
and cash...
$188,816K
(188.94%↑ Y/Y)
Canceled cashflow
$604K
Net cash provided by
(used in) operating...
$19,959K
(499.42%↑ Y/Y)
Canceled cashflow
$54,892K
Net change in cash
and cash...
-$604K
(99.72%↑ Y/Y)
Canceled cashflow
$19,959K
Proceeds from issuance of
convertible debt, net of...
$305,434K
Proceeds from issuance of
common stock under...
$2,090K
(993.16%↑ Y/Y)
Proceeds from issuance of
common stock upon...
$1,273K
Proceeds received from
capped call...
$77K
Impairment charges
-$27,127K
(-235.36%↓ Y/Y)
Gain on debt
extinguishment
$11,181K
Accounts receivable, net
$7,981K
(2110.33%↑ Y/Y)
Accounts payable and
other liabilities
-$4,803K
(-162.23%↓ Y/Y)
Prepaid and other assets
$1,457K
(28.26%↑ Y/Y)
Operating lease
liabilities
-$1,300K
(-595.19%↓ Y/Y)
Deferred income tax
liabilities, net
$626K
(-59.19%↓ Y/Y)
Other adjustments
-$417K
(-22.65%↓ Y/Y)
Net cash used in
financing activities
-$12,244K
(93.92%↑ Y/Y)
Canceled cashflow
$308,874K
Net cash used in
investing activities
-$8,319K
(-44.58%↓ Y/Y)
Repayment of convertible
debt
$262,890K
(30.63%↑ Y/Y)
Premiums paid for capped
call confirmations
$28,747K
Repurchases of common stock
$25,000K
Employee taxes paid
related to net share...
$3,168K
Repayment of financing
leases
$1,313K
Purchases of property and
equipment
$8,219K
(-24.06%↓ Y/Y)
Purchase of convertible
note
$100K
Buy us a coffee
NEOGENOMICS INC (NEO)
NEOGENOMICS INC (NEO)